Laboratory Corp of America Holdings - Company Profile
Powered by 
All the data and insights you need on Laboratory Corp of America Holdings in one report.
$295
- Save hours of research time and resources with
our up-to-date Laboratory Corp of America Holdings Strategy Report
- Understand Laboratory Corp of America Holdings position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Laboratory Corp of America Holdings (LabCorp) develops and provides a broad range of clinical laboratory services to various client groups including independent physician and physician groups, hospitals, managed care organizations and other institutions.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Business Segments
Overview
Conducts independent clinical laboratory business through a network of primary laboratories and patient service centers and STAT laboratories. It also provides a range of specialty testing services in the areas of women's health, infectious disease, endocrinology, oncology, allergy, diagnostic genetics, cardiovascular disease, coagulation, toxicology, pharmacogenetics, and medical drug monitoring. The company also carries out various other testing services such as parentage and occupational testing and wellness testing for employers. Major tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, Hemoglobin A1C, PSA, STD tests, hepatitis C(HCV) tests, thyroid tests, Vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Key specialty testing services include esoteric testing, cancer diagnostics, and other complex procedures. Strives to improve quality and productivity while lowering costs throughout all phases of its operations.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers a wide range of contract research services including R&D and market access services to biopharmaceutical and medical device companies across the world. Major preclinical service offerings include research models, lead optimization, analytical services, safety assessment, and chemistry manufacturing and control; (CMC) services for drug development; central laboratory services; full management of Phase II through IV clinical studies; clinical development and commercialization services and CDD technology-enabled solutions Views acquisitions as a critical growth driver for the segment. In line with this strategy, the company acquired Envigo's nonclinical contract research services business.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer